School of Clinical Dentistry , University of Sheffield , 19 Claremont Crescent , Sheffield S10 2TA , U.K.
Department of Chemistry , University of Sheffield , Brook Hill , Sheffield S3 7HF , U.K.
Mol Pharm. 2019 Sep 3;16(9):3948-3956. doi: 10.1021/acs.molpharmaceut.9b00535. Epub 2019 Aug 15.
Many oral mucosal conditions cause considerable and prolonged pain that to date has been difficult to alleviate via topical delivery, and the use of injection causes many patients dental anxiety and needle-prick pain. Therefore, developing a noninjectable drug delivery system as an alternative administration procedure may vastly improve the health and wellbeing of these patients. Recent advances in the development of mucoadhesive electrospun patches for the direct delivery of therapeutics to the oral mucosa offer a potential solution, but as yet, the release of local anesthetics from this system and their uptake by oral tissue have not been demonstrated. Here, we demonstrate the fabrication of lidocaine-loaded electrospun fiber patches, drug release, and subsequent uptake and permeation through the porcine buccal mucosa. Lidocaine HCl and lidocaine base were incorporated into the electrospun patches to evaluate the difference in drug permeation for the two drug compositions. Lidocaine released from the lidocaine HCl-containing electrospun patches was significantly quicker than from the lidocaine base patches, with double the amount of drug released from the lidocaine HCl patches in the first 15 min (0.16 ± 0.04 mg) compared to that from the lidocaine base patches (0.07 ± 0.01 mg). The permeation of lidocaine from the lidocaine HCl electrospun patches through ex vivo porcine buccal mucosa was also detected in 15 min, whereas permeation of lidocaine from the lidocaine base patch was not detected. Matrix-assisted laser desorption ionization-mass spectrometry imaging was used to investigate localization of lidocaine within the oral tissue. Lidocaine in the solution as well as from the mucoadhesive patch penetrated into the buccal mucosal tissue in a time-dependent manner and was detectable in the lamina propria after only 15 min. Moreover, the lidocaine released from lidocaine HCl electrospun patches retained biological activity, inhibiting veratridine-mediated opening of voltage-gated sodium channels in SH-SY5Y neuroblastoma cells. These data suggest that a mucoadhesive electrospun patch may be used as a vehicle for rapid uptake and sustained anesthetic drug delivery to treat or prevent oral pain.
许多口腔黏膜疾病会引起相当大且持久的疼痛,迄今为止,通过局部给药很难缓解这种疼痛,而注射给药会引起许多患者的牙科焦虑和针刺疼痛。因此,开发一种非注射药物递送系统作为替代给药程序可能会极大地改善这些患者的健康和福祉。最近在开发用于将治疗剂直接递送到口腔黏膜的粘膜粘附性静电纺丝贴片方面取得了进展,为解决这一问题提供了一种潜在的解决方案,但迄今为止,尚未证明局部麻醉剂从该系统中的释放及其被口腔组织吸收。在这里,我们展示了载有盐酸利多卡因的静电纺丝纤维贴片的制备、药物释放以及随后通过猪颊黏膜的吸收和渗透。将盐酸利多卡因和利多卡因碱掺入静电纺丝贴片,以评估两种药物成分的药物渗透差异。载有盐酸利多卡因的静电纺丝贴片释放的利多卡因明显快于载有利多卡因碱的贴片,在前 15 分钟内,载有盐酸利多卡因的贴片释放的药物量是载有利多卡因碱的贴片的两倍(0.16±0.04mg 比 0.07±0.01mg)。在 15 分钟内还检测到盐酸利多卡因从载有盐酸利多卡因的静电纺丝贴片通过离体猪颊黏膜的渗透,而从载有利多卡因碱的贴片未检测到渗透。基质辅助激光解吸电离-质谱成像被用于研究利多卡因在口腔组织中的定位。溶液中的利多卡因以及来自粘膜粘附性贴片的利多卡因以时间依赖性方式渗透到颊黏膜组织中,仅在 15 分钟后就在固有层中可检测到。此外,从利多卡因盐酸盐静电纺丝贴片释放的利多卡因保持生物活性,抑制辣椒素介导的 SH-SY5Y 神经母细胞瘤细胞中电压门控钠通道的开放。这些数据表明,粘膜粘附性静电纺丝贴片可作为载体,用于快速吸收和持续麻醉药物递送,以治疗或预防口腔疼痛。